Molecular Partners AG (MOLN) CHF0.1

Sell:4.10 CHFBuy:4.20 CHF0.02 CHF (0.36%)

Prices delayed by at least 15 minutes
Sell:4.10 CHF
Buy:4.20 CHF
Change:0.02 CHF (0.36%)
Deal now
Prices delayed by at least 15 minutes
Sell:4.10 CHF
Buy:4.20 CHF
Change:0.02 CHF (0.36%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.

Key people

Patrick Amstutz
Chief Executive Officer, Executive Director, Member of the Management Board
Alexander Zurcher
Chief Operating Officer, Member of the Management Board
Renate Gloggner
Executive Vice President - People and Community, Member of the Management Board
Michael Tobias Stumpp
Executive Vice President - Projects, Member of the Management Board
Philippe Legenne
Chief Medical Officer
William M. Burns
Non-Executive Independent Chairman of the Board
Agnete B. Fredriksen
Non-Executive Independent Director
Dominik Hoechli
Non-Executive Independent Director
Steven H. Holtzman
Non-Executive Independent Director
Sandip S. Kapadia
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    MOLN
  • Location
    Switzerland
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    CH0256379097
  • Market cap
    CHF 169.37m
  • Employees
    162
  • Shares in issue
    40.37m
  • Exchange
    SIX Swiss Exchange
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.